The burden of neuropathic pain: a systematic review and meta-analysis of health utilities
- PMID: 20227832
- DOI: 10.1016/j.pain.2010.02.034
The burden of neuropathic pain: a systematic review and meta-analysis of health utilities
Abstract
Patients with neuropathic pain (NeuP) experience substantially lower health-related quality of life (HRQoL) than the general population. The aim of this systematic review and meta-analysis is to test the hypothesis that NeuP is associated with low levels of health utility. A structured search of electronic databases (MEDLINE, EMBASE, Cochrane Library and CINAHL) was undertaken. Reference lists of retrieved reports were also reviewed. Studies reporting utility single-index measures (preference based) in NeuP were included. Random effects meta-analysis was used to pool EQ-5D index utility estimates across NeuP conditions. The association of utilities and pre-defined factors (NeuP condition, patient age, sex, duration and severity of pain and method of utility scoring) was examined using meta-regression. Twenty-four studies reporting health utility values in patients with NeuP were included in the review. Weighted pooled utility score across the studies varied from a mean of 0.15 for failed back surgery syndrome to 0.61 for post-herpetic neuralgia and diabetic neuropathy. Although there was substantial heterogeneity (P<0.0001) across studies, we found little variation in utility as a function of patient and study characteristics. The single exception was a significant relationship (P<0.0001) between increasing neuropathic pain severity and a reduction in utility. This study confirms the hypothesis that patients with NeuP experience low utilities and therefore low HRQoL. However, the contribution of non-NeuP co-morbidity remains unclear. Neuropathic pain severity emerged as a primary predictor of the negative health impact of NeuP.
Copyright 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Acupuncture for neuropathic pain in adults.Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD012057. doi: 10.1002/14651858.CD012057.pub2. Cochrane Database Syst Rev. 2017. PMID: 29197180 Free PMC article.
-
Oxycodone for neuropathic pain in adults.Cochrane Database Syst Rev. 2016 Jul 28;7(7):CD010692. doi: 10.1002/14651858.CD010692.pub3. Cochrane Database Syst Rev. 2016. PMID: 27465317 Free PMC article.
-
Patient education in the management of coronary heart disease.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3. Cochrane Database Syst Rev. 2017. PMID: 28658719 Free PMC article.
Cited by
-
Hyperbaric oxygen treatment at various stages following chronic constriction injury produces different antinociceptive effects via regulation of P2X4R expression and apoptosis.PLoS One. 2015 Mar 19;10(3):e0120122. doi: 10.1371/journal.pone.0120122. eCollection 2015. PLoS One. 2015. PMID: 25789619 Free PMC article.
-
Effect of Neural Mobilization on Nerve-Related Neck and Arm Pain: A Randomized Controlled Trial.Physiother Can. 2020 Nov 1;72(4):408-419. doi: 10.3138/ptc-2018-0056. Physiother Can. 2020. PMID: 35110815 Free PMC article.
-
Pain-resolving immune mechanisms in neuropathic pain.Nat Rev Neurol. 2023 Apr;19(4):199-220. doi: 10.1038/s41582-023-00777-3. Epub 2023 Mar 1. Nat Rev Neurol. 2023. PMID: 36859719 Review.
-
Role of macrophages and activated microglia in neuropathic pain associated with chronic progressive spinal cord compression.Sci Rep. 2019 Oct 30;9(1):15656. doi: 10.1038/s41598-019-52234-1. Sci Rep. 2019. PMID: 31666661 Free PMC article.
-
Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain.Antioxidants (Basel). 2022 Dec 8;11(12):2420. doi: 10.3390/antiox11122420. Antioxidants (Basel). 2022. PMID: 36552628 Free PMC article. Review.
References
-
- Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153-1169.
-
- Bremner KE, Chong CA, Tomlinson G, Alibhai SM, Krahn MD. A review and meta-analysis of prostate cancer utilities. Med Decis Making. 2007;27:288-298.
-
- Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M, Coons SJ. A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics. 2006;24:751-765.
-
- Cruccu G, Aziz TZ, Garcia-Larrea L, Hansson P, Jensen TS, Lefaucheur JP, Simpson BA, Taylor RS. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14:952-970.
-
- DerSimonsen R, Laird N. Meta analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical